Clinical Supply Agreement Template for the United States

A Clinical Supply Agreement establishes the legal framework between pharmaceutical companies, contract manufacturers, and research organizations for supplying investigational products during clinical trials. This contract ensures your clinical trial supply chain meets stringent regulatory requirements while protecting all parties involved in the manufacturing and distribution process.

When do you need this document?

You need a Clinical Supply Agreement when initiating any clinical trial requiring manufactured investigational products. This includes Phase I through Phase III trials where a pharmaceutical sponsor contracts with a Contract Manufacturing Organization to produce clinical supplies, when research institutions need specialized manufacturing for investigational compounds, or when multiple parties collaborate on clinical research requiring controlled substance distribution. The agreement becomes essential when transferring manufacturing responsibilities from internal facilities to external contractors, ensuring regulatory compliance throughout the supply chain. You also need this document when establishing backup manufacturing arrangements to prevent clinical trial delays due to supply shortages.

Key legal considerations

Quality requirements form the cornerstone of any Clinical Supply Agreement, mandating strict adherence to Good Manufacturing Practice standards and FDA quality control protocols. Manufacturing specifications must be precisely defined, including batch records, testing requirements, and release criteria that comply with 21 CFR Part 312 regulations. Intellectual property protection clauses safeguard proprietary formulations and manufacturing processes while maintaining confidentiality throughout the supply relationship. Liability allocation provisions address potential product defects, regulatory violations, and clinical trial delays, with indemnification clauses protecting parties from third-party claims. Supply chain security measures must address drug serialization requirements, cold chain maintenance for biologics, and secure transportation protocols. Regulatory compliance sections ensure both parties maintain current FDA registrations, implement proper change control procedures, and facilitate regulatory inspections when required.

Legal requirements in United States

United States Clinical Supply Agreements must comply with the comprehensive Food, Drug, and Cosmetic Act framework governing pharmaceutical manufacturing and distribution. Manufacturers must maintain current FDA registration and comply with 21 CFR Part 210 and 211 Good Manufacturing Practice regulations throughout the supply period. The agreement must address Investigational New Drug application requirements under 21 CFR Part 312, ensuring proper documentation and regulatory reporting. HIPAA compliance provisions protect patient privacy when clinical supplies contain identifying information or require special handling protocols. Public Health Service Act requirements apply when dealing with biological products, mandating additional safety and efficacy documentation. The contract must establish clear procedures for FDA inspections, adverse event reporting, and regulatory correspondence, ensuring seamless communication between all parties and regulatory authorities.